Talphera Inc (TLPH) Actualités

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Talphera Announces Third Quarter 2024 Financial Results and Provides Corporate Update

Talphera Announces Third Quarter 2024 Financial Results and Provides Corporate Update PR Newswire SAN MATEO...

Talphera to Host Third Quarter 2024 Financial Results and Corporate Update Call and Webcast on Wednesday, November 13, 2024

Talphera to Host Third Quarter 2024 Financial Results and Corporate Update Call and Webcast on Wednesday...

Form 3 - Initial statement of beneficial ownership of securities

Talphera to Participate in Fireside Chat at the 2024 Maxim Healthcare Virtual Summit

Talphera to Participate in Fireside Chat at the 2024 Maxim Healthcare Virtual Summit PR Newswire SAN MATEO...

Form 8-K - Current report

Talphera to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

Talphera to Participate in the H.C. Wainwright 26th Annual Global Investment Conference PR Newswire SAN MATEO...

Form 4 - Statement of changes in beneficial ownership of securities

Talphera Announces First Patient Enrolled in the Registrational Trial Evaluating Nafamostat for Anticoagulation of the Extracorporeal Circuit

Talphera Announces First Patient Enrolled in the Registrational Trial Evaluating Nafamostat for...

Form S-8 - Securities to be offered to employees in employee benefit plans

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Talphera Announces Second Quarter 2024 Financial Results and Provides Corporate Update

Talphera Announces Second Quarter 2024 Financial Results and Provides Corporate Update PR Newswire SAN MATEO...

Talphera to Host Second Quarter 2024 Financial Results and Corporate Update Call and Webcast on Wednesday, August 14, 2024

Talphera to Host Second Quarter 2024 Financial Results and Corporate Update Call and Webcast on Wednesday...

Form 4 - Statement of changes in beneficial ownership of securities